Week in Weed – April 25, 2026 – StratCann Insights
This article provides weekly cannabis clinical updates April 25 2026 from StratCann. It highlights emerging regulatory news and clinical relevance impacting patient care. Clinicians should review these updates to stay informed on industry developments.
IM Cannabis Posts C$54.7M Revenue and Positive Cash Flow
IM Cannabis revenue report reveals C$54.7 million in earnings with positive cash flow. This financial update provides insight into the company's 2026 performance. The report focuses on business results rather than clinical data.
Week in Weed – March 28, 2026 – StratCann Insights
This Week in Weed highlights notable clinical interest cannabis developments from March 28, 2026. Emerging findings and policy updates are closely monitored for clinical relevance. Evidence-based insights support informed decision-making in cannabis…
Jushi Holdings Inc. Completes Credit Facility Refinancing
Corporate refinancing cannabis industry activities like Jushi Holdings' recent credit facility refinancing represent financial restructuring. These developments have minimal direct clinical relevance for patient care. Understanding the distinction helps…